Sci. Pharm. 2010; 78: 103–115
In vivo Bioavailability and Therapeutic Assessment of Host-Guest Inclusion Phenomena for the Hydrophobic Molecule Etodolac: Pharmacodynamic and Pharmacokinetic Evaluation
Vivek Ranjan SINHA *, AMITA, Honey GOEL
University Institute of Pharmaceutical Sciences, Panjab University,160014,Chandigarh, India .
* Corresponding author. E-mail: firstname.lastname@example.org (V. R. Sinha)
The aim of present investigation was 1) to evaluate the in vivo bioavailability of an Etodolac (ETD)-β-cyclodextrin (β-CD) inclusion complex system prepared by kneading and spray drying techniques in rats, 2) to study the pharmacodynamic parameters in various animal models for analyzing the therapeutic response and, 3) to evaluate the pharmacokinetic profile of the drug administered. Inclusion complexation with β-CD enhanced the solubility of the drug, improved bioavailability and reduced ulcerogenicity of ETD in rats. Pharmacodynamic studies were carried out in normal LACA mice and pharmacokinetic evaluation was done in male Wistar rats. Pharmacokinetic parameters evaluated for the inclusion complexes revealed good correlation. The minimum dose necessary to produce analgesic or anti-arthritic activity was also decreased, indicating that the host-guest strategy that uses β-CD and ETD was very effective and could be successfully employed in the preparation of pharmaceutical formulations of anti-arthritics and analgesics.
ETD • β-Cyclodextrin • Inclusion-complexes • Bioavailability • Ulcerogenicity
Received September 17th, 2009 | Accepted January 18th, 2009 | Published Online January 18th, 2009